Boehringer Ingelheim Pharmaceuticals Inc.’s response to EPA’s
January 7, 2009 letter

 This information is classified as Confidential Business Information
(CBI).  

CBI is located at EPA headquarters 1310 L St NW.

 PAGE   

 PAGE   1 

